Infosys: Is this all overdone?
Given the damage that the Infosys episode has caused, one can argue that the company should have been more forthcoming. There were...
Sun Pharma: What investors should ask of its board
The whistle-blower allegations have raised governance concerns at Sun Pharma. Given its current structure, and the new SEBI-accepted...